Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ·Healthcare·Biotechnology
$2.72
-7.02%
Mkt Cap $167.28M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | $9.38M | — | — | -$0.18 | -$0.14 | +22.22% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.22 | -$0.15 | +31.82% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.25 | -$0.19 | +24.00% | — | — |
| Q2 2025 May 12, 2025 | $28.00M | $70.00M | +150.00% | $0.02 | $0.98 | +4800.00% | — | — |
| Q1 2025 Mar 6, 2025 | — | — | — | -$0.31 | -$0.28 | +9.68% | — | — |
| Q4 2024 Nov 5, 2024 | — | — | — | -$0.37 | -$0.28 | +24.32% | — | — |
| Q3 2024 Aug 6, 2024 | — | — | — | -$0.39 | -$0.36 | +7.69% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.44 | -$0.35 | +20.45% | — | — |
| Q1 2024 Mar 12, 2024 | — | $4.89M | — | -$0.47 | -$0.34 | +27.66% | — | — |
| Q4 2023 Nov 6, 2023 | — | — | — | -$0.49 | -$0.45 | +8.16% | — | — |
| Q3 2023 Aug 11, 2023 | — | — | — | -$0.54 | -$0.52 | +3.70% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$0.61 | -$0.57 | +6.56% | — | — |
| Q1 2023 Mar 9, 2023 | — | — | — | -$0.63 | -$0.59 | +6.35% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$0.64 | -$0.60 | +6.25% | — | — |
| Q3 2022 Aug 9, 2022 | — | — | — | -$0.68 | -$0.63 | +7.35% | — | — |
| Q2 2022 May 11, 2022 | — | — | — | -$0.75 | -$0.70 | +6.67% | — | — |
| Q1 2022 Mar 17, 2022 | — | — | — | -$1.01 | -$0.71 | +29.70% | — | — |
| Q4 2021 Nov 8, 2021 | — | — | — | -$0.98 | -$0.97 | +1.02% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$0.87 | -$0.95 | -9.20% | — | — |
| Q2 2021 May 7, 2021 | — | — | — | -$0.67 | -$0.84 | -25.37% | — | — |